Cardiac MRI right atrial area measurement thresholds for risk stratification in patients with PAH

F. Alandejani ( Sheffield, United Kingdom), E. Tubman ( Sheffield, United Kingdom), Y. Shahin ( Sheffield, United Kingdom), R. Lewis ( Sheffield, United Kingdom), K. Dwivedi ( Sheffield, United Kingdom), D. Alkhanfar ( Sheffield, United Kingdom), S. Alabed ( Sheffield, United Kingdom), C. Johns ( Sheffield, United Kingdom), P. Garg ( Sheffield, United Kingdom), R. Condliffe ( Sheffield, United Kingdom), A. Lawrie ( Sheffield, United Kingdom), J. Wild ( Sheffield, United Kingdom), D. Kiely ( Sheffield, United Kingdom), A. Swift ( Sheffield, United Kingdom)

Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Session: Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Session type: E-poster session
Number: 1522
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Alandejani ( Sheffield, United Kingdom), E. Tubman ( Sheffield, United Kingdom), Y. Shahin ( Sheffield, United Kingdom), R. Lewis ( Sheffield, United Kingdom), K. Dwivedi ( Sheffield, United Kingdom), D. Alkhanfar ( Sheffield, United Kingdom), S. Alabed ( Sheffield, United Kingdom), C. Johns ( Sheffield, United Kingdom), P. Garg ( Sheffield, United Kingdom), R. Condliffe ( Sheffield, United Kingdom), A. Lawrie ( Sheffield, United Kingdom), J. Wild ( Sheffield, United Kingdom), D. Kiely ( Sheffield, United Kingdom), A. Swift ( Sheffield, United Kingdom). Cardiac MRI right atrial area measurement thresholds for risk stratification in patients with PAH. 1522

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
CT pulmonary angiography-derived right atrial area can risk stratify patients with PAH and PH
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Year: 2019

Right ventricular stroke volume measured by MRI as indicator of treatment outcome and predictor of death in patients with pulmonary hypertension
Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy
Year: 2005


MRI derived left atrial volume index predicts treatment response in patients with PAH
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016

MRI assessment of right atrial volume and function in pulmonary hypertension
Source: Annual Congress 2012 - Functional imaging of the lung parenchyma, tumours and circulation
Year: 2012

Assessment of atrial arrhythmogenic risk factors with body surface potential mapping in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 351s
Year: 2005

Can right ventricle imaging improve risk stratification in pulmonary arterial hypertension?
Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management
Year: 2021


Agreement of right ventricular enlargement assessed by CT angiogram for risk stratifying normotense patients with acute symptomatic pulmonary embolism
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010

Prognostic value of right ventricular dilatation in patients with low risk pulmonary embolism
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017


Diagnostic accuracy of right ventricular trabecular mass measurements as measured on cardiac MRI in suspected pulmonary hypertension
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019


Right ventricular dyssynchrony measured using speckle tracking strain as a predictive factor in pulmonary hypertension patients
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011

Risk stratification of PE and evaluation of the right ventricle
Source: ERS Course 2019 - Masterclass in pulmonary embolism
Year: 2019


Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension
Source: Eur Respir J, 53 (4) 1802067; 10.1183/13993003.02067-2018
Year: 2019



Right ventricular mechanical efficiency measured in PAH patients using PET
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Year: 2009


Predictors of abnormalities of the right heart chambers evaluated by echocardiography during OSA
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020


Prognostic value of right ventricular dilatation in patients with low-risk pulmonary embolism
Source: Eur Respir J, 50 (6) 1701611; 10.1183/13993003.01611-2017
Year: 2017



The value of tools to assess pulmonary arterial hypertension
Source: Eur Respir Rev 2011; 20: 222-235
Year: 2011



Exercise cardiac MRI-derived right ventriculo-arterial coupling ratio detects early right ventricular maladaptation in PAH
Source: Eur Respir J 2016; 48: 1797-1800
Year: 2016


In patients with intermediate-low risk pulmonary embolism: cardiac enzyme or right ventricle dysfunction or sPESI
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017

Echocardiographic parameters of right ventricular dysfunction in pulmonary hypertension. Usefulness of speckle tracking longitudinal strain of the right ventricle
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010


Echocardiographic measures of right ventricular function poorly correlate with changes in contractility and coupling in treatment naïve patients with pulmonary artery hypertension before and after therapy.
Source: International Congress 2017 – Cardiac function assessment in pulmonary hypertension
Year: 2017